Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

Global Afib Patient Registry Shows New Tools Needed to Assess Patient Risk
News | Patient Engagement | June 17, 2019

June 17, 2019 – Initial results from the AVIATOR 2...

Boston Scientific Initiates OPTION Trial of Watchman FLX
News | Left Atrial Appendage (LAA) Occluders | June 12, 2019

June 12, 2019 — Boston Scientific Corp. has initiated the OPTION trial to compare safety and effectiveness of the...

Algorithm Steers Catheters to Right Spot to Treat Atrial Fibrillation

Using human AFib simulations, the researchers demonstrated that their technique can stop the catheter at the right target and identify the source type with a 95.25 percent success rate. This new algorithm also is effective in scarred tissue, which makes ablation more challenging, and has a 99 percent detection rate regardless of the scar size. Image courtesy of Florida Atlantic University.

News | EP Mapping and Imaging Systems | May 28, 2019

May 28, 2019 — Researchers have developed the first algorithm that can locate patient-specific...

Medtronic Presents Positive Renal Denervation Results at EuroPCR 2019
News | Renal Denervation | May 23, 2019

May 23, 2019 – Investigators unveiled late-breaking clinical data from a first-of-its-kind physician sponsored...

Biosense Webster Launches Cartonet Analytics Software for Electrophysiology
Technology | Analytics Software | May 16, 2019

May 16, 2019 — Johnson & Johnson Medical Devices Companies announced the launch of Biosense Webster Inc.’s...

Medtronic's extravascular ICD EV-ICD system data was presented at HRS 2019.

Data from the first-in-human use of Medtronic's extravascular ICD (EV-ICD) system was presented at HRS 2019.

Blog | HRS | May 16, 2019

 

The Heart Rhythm Society (HRS) 2019 Annual...

Biosense Webster Announces Initial Results From First-in-Human QDOT-FAST Study
News | Ablation Systems | May 16, 2019

May 16, 2019 — Johnson & Johnson Medical Devices Companies announced that Biosense Webster, Inc.’s QDot Micro...

CardioFocus Announces Results From HeartLight X3 Ablation System Pivotal Study
News | Ablation Systems | May 16, 2019

May 16, 2019 — CardioFocus Inc. announced the presentation of results from its...

HRS 2019 late breaking trials, late breaking presentations for the biggest news in electrophysiology (EP). #HRS #HRS2019 #HRS19
Feature | HRS | May 15, 2019 | Dave Fornell, Editor

May 15, 2019 — The Heart Rhythm Society (HRS) had 21 late-...

An screen shot of the Abbott Focal Impulse and Rotor Modulated (FIRM)-guided ablation system used to guide AF ablation procedures.

An screen shot of the Abbott Focal Impulse and Rotor Modulated (FIRM)-guided ablation system used to guide AF ablation procedures. 

News | Atrial Fibrillation | May 14, 2019 | Dave Fornell, Editor

May 14, 2019 – The first prospective, multicenter, randomized, controlled trial to compare conventional pulmonary...

The Parasym Salustim device ear clip stimulates the vagus nerve, which was found to reduced AF burden compared with a sham procedure in the TREAT AF trial.

The Parasym Salustim device ear clip stimulates the vagus nerve, which was found to reduced AF burden compared with a sham procedure in the TREAT AF trial. 

News | Atrial Fibrillation | May 13, 2019

May 13, 2019 — A randomized clinical trial effectively used nerve stimulation through an ear clip to reduce...

More than 60,000 from the general population in Belgium were screened for AFib using only a smartphone app in the DIGITAL-AF II study. The study used the FibriCheck app found 791 participants has measurements indicative for AF.

More than 60,000 from the general population in Belgium were screened for AFib using only a smartphone app in the DIGITAL-AF II study. The study used the FibriCheck app found 791 participants has measurements indicative for AF.

News | Atrial Fibrillation | May 13, 2019

May 13, 2019 — A digital screening for...

A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beam will ablate for a noninvasive pulmonary vein isolation procedure. Varian acquires, buys, purchases Cyberheart.

A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beams will ablate for a noninvasive pulmonary vein isolation procedure to treat an arrhythmia.

Feature | Ablation Systems | May 10, 2019 | Dave Fornell, Editor

May 10, 2019 — Radiation oncology vendor Varian announced it acquired the start-up company CyberHeart, which has...

Overlay Init